Development and Testing of an Identity Measure for Transgender and Gender Diverse Persons
跨性别者和性别多元化人士身份测量的开发和测试
基本信息
- 批准号:10698182
- 负责人:
- 金额:$ 19.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-15 至 2024-09-14
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdoptedAffectAgeBehavioral MechanismsCognitiveCommunitiesDataDevelopmentDimensionsDiscriminationEnrollmentEvaluationExposure toFaceGenderGender IdentityHIVHealthHealth StatusIndividualInterventionInterviewLinear ModelsMeasuresMental DepressionMethodsOutcomeParticipantPersonsPopulationPopulation HeterogeneityProcessPsychological TheoryPsychometricsPublic HealthResearchResearch PersonnelRiskRisk BehaviorsSamplingSelf PerceptionSocial statusSourceTestingValidity and ReliabilityViralWorkcofactorgender affirmationgender diversitygender minority communitygender minority grouphealth disparityinsightinstrumentminority stresspre-exposure prophylaxisresilienceresponsesexsocialsocial relationshipssocial stigmasubstance usetheoriestooltransfemininetransgendertransmasculinetransmission processuptakeverbal
项目摘要
Abstract
Evidence demonstrates that transgender and gender diverse (TGD) persons are at dramatically elevated risk
for HIV and a number of other detrimental health outcomes largely as a result of pervasive exposure to gender-
based stigma and discrimination. Such prejudicial treatment is internalized by TGD persons as “identity non-
verification,” a well-established behavioral mechanism in Identity Theory which has yet to be broadly adopted
by researchers studying TGD populations. This study would develop the first multidimensional measure of
TGD persons' gender identities using Identity Theory's established metrics (e.g., identity standards, reflected
appraisals, salience / prominence / commitment ratings) and mechanisms (e.g., identity non-verification,
identity corrective responses). The study would occur in two stages, beginning with a Development Stage in
which in-depth interviews are carried out with a purposively sampled group of TGD persons evenly split by
age, HIV status, and gender identity (N = 24 participants each) over the course of six months followed by a
period of six weeks to analyze the interview data and formulate initial dimensions of the gender identity
measure. Six weeks of cognitive debriefing interviews (n = 6) would then confirm the face validity of the new
measure and allow for fine-tuning of items. This would conclude the Development Stage and would commence
the Testing Stage (N = 150), in which the reliability and validity of the new measure could be established, and
a test of how identity non-verification is associated with critical health outcomes can be carried out. A deeper
and more granular understanding of how TGD persons see themselves, how they believe other people see
them, and how differences between these two constructs are associated with HIV-related outcomes and risks
(including exposure to HIV and uptake/adherence to ART or PEP/PrEP) could generate new hypotheses,
better research questions, and new methods of intervening in one of the populations most affected by HIV in
the US.
摘要
有证据表明,跨性别和性别多样性(TGD)的人在显着增加的风险
艾滋病毒和其他一些有害的健康结果,主要是由于普遍暴露于性别-
基于耻辱和歧视。这种歧视性待遇被TGD人内化为“身份非歧视”,
验证”是认同理论中一个成熟的行为机制,但尚未被广泛采用
研究TGD人群的研究人员。这项研究将开发第一个多维度的措施,
TGD人的性别认同使用身份理论的既定指标(例如,身份标准,反映
评价、显著性/突出性/承诺评级)和机制(例如,身份不验证,
身份纠正响应)。该研究将分两个阶段进行,首先是开发阶段,
深入访谈是与一组有目的的抽样TGD人进行的,
年龄、HIV状态和性别认同(各N = 24名参与者)在6个月的时间内,
用六周时间分析访谈数据,并制定性别认同的初步维度
measure.六周的认知汇报访谈(n = 6)将证实新的表面效度
测量并允许对项目进行微调。这将结束开发阶段,并开始
测试阶段(N = 150),在该阶段可以建立新测量的可靠性和有效性,以及
可以对身份不核实与关键健康结果之间的关系进行测试。更深
更细致地了解TGD患者如何看待自己,他们如何相信其他人的看法,
以及这两种结构之间的差异如何与艾滋病毒相关的结果和风险相关
(包括接触艾滋病毒和接受/坚持抗逆转录病毒疗法或接触前预防/准备)可能会产生新的假设,
更好的研究问题,以及干预受艾滋病毒影响最严重的人群之一的新方法,
美方
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jesse Bradford Fletcher其他文献
Jesse Bradford Fletcher的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jesse Bradford Fletcher', 18)}}的其他基金
Development and Testing of an Identity Measure for Transgender and Gender Diverse Persons
跨性别者和性别多元化人士身份测量的开发和测试
- 批准号:
10548085 - 财政年份:2022
- 资助金额:
$ 19.37万 - 项目类别:
Intervention to Reduce Internalized Stigma (IRIS) among People Living with HIV who use Substances
减少使用药物的艾滋病毒感染者的内在耻辱 (IRIS) 的干预措施
- 批准号:
10548369 - 财政年份:2022
- 资助金额:
$ 19.37万 - 项目类别:
相似海外基金
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 19.37万 - 项目类别:
Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 19.37万 - 项目类别:
Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 19.37万 - 项目类别:
Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 19.37万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 19.37万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 19.37万 - 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 19.37万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 19.37万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 19.37万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 19.37万 - 项目类别:
Fellowship Programs